T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer
Conditions: HER2-positive Breast Cancer; Breast Cancer; Breast Cancer Stage; Recurrent Breast Cancer; Metastatic Breast Cancer; HER2 Positive Breast Carcinoma Interventions: Drug: Palbociclib; Drug: T-DM1 Sponsors: University of Arizona; Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | HER2 | Pfizer